|Articles|August 9, 2016
Evidera to Join PPD
PPD announces the acquisition of Evidera, an evidence-based solutions provider.
Advertisement
PPD announces the acquisition of Evidera, an evidence-based solutions provider. As a subsidiary of PPD, Evidera will be deliver peri- and post-approval studies, health economics, outcomes research, epidemiology and market access consulting.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
2
Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial
3
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
4
How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
